Guidelines for Veterinary Medicinal Products
This article was originally published in SRA
You may also be interested in...
Biocon has reported FDA clearance for its Malaysian insulin facility, while Lupin and Xellia have also received plant approvals. Meanwhile, Alembic has seen mixed fortunes, receiving both Form 483 observations and an EIR.
Lannett has begun marketing a US rival to Adderall XR through a partnership with Elite and SunGen. But the product will face competition from a range of other generics.
Dutch foot-care specialists TheOTCLab launches what it claims to be the world's first fungal nail plaster.